
Volta Labs: Revolutionizing genomics with digital fluidics for advanced biological research.
Volta Labs, Inc. is a genomics applications company dedicated to unlocking the utility of genomics for the world. The company has developed an innovative digital fluidics platform designed to enhance the performance and scalability of sample preparation in genomics, ensuring unparalleled consistency. This technology transforms biological research and analyses, enabling scientists to focus on advancing the boundaries of biology. Volta Labs operates at the intersection of engineering and biology, offering push-button sample preparation compatible with any sequencer.
Volta Labs has made significant strides in the genomics field, notably unveiling their digital fluidics technology at the Advances in Genome Biology and Technology (AGBT) conference. Their platform leverages electrowetting for automated next-generation sequencing (NGS), showcasing their commitment to innovation and automation in genomics research. Through these advancements, Volta Labs is making a substantial impact on the efficiency and accuracy of genomic studies, contributing to the broader scientific community's efforts to understand and utilize genetic information.

Inscripta
inscripta.com

WhiteLab Genomics
whitelabgx.com

Singular Genomics

XGenomes
xgenomes.com

Streamline Genomics

Via Scientific
viascientific.com

MicroPure Genomics

Nest Genomics
nestgenomics.com

Sequegenics
sequegenics.com

Scispot
scispot.io

Aqueduct Fluidics

Ovation
ovation.io

Flexomics
flexomics.com

Ginkgo Bioworks
ginkgobioworks.com

Lamin
lamin.ai
Companies similar to Volta Labs, Inc. include Inscripta, WhiteLab Genomics, Singular Genomics and XGenomes.
Volta Labs, Inc. was founded in 2018.
Volta Labs, Inc.'s headquarters is located in Cambridge, MA, US.
Volta Labs, Inc.'s most recent funding round was for $4.3M (USD) in January 2024.
As of Jan 12, 2024, Volta Labs, Inc. has raised a total of $24.4M (USD).
Volta Labs, Inc. has 50 employees as of Apr 28, 2024.